Arimide, D.A.; Szojka, Z.I.; Zealiyas, K.; Gebreegziabxier, A.; Adugna, F.; Sasinovich, S.; Björkman, P.; Medstrand, P.
Pre-Treatment Integrase Inhibitor Resistance and Natural Polymorphisms among HIV-1 Subtype C Infected Patients in Ethiopia. Viruses 2022, 14, 729.
https://doi.org/10.3390/v14040729
AMA Style
Arimide DA, Szojka ZI, Zealiyas K, Gebreegziabxier A, Adugna F, Sasinovich S, Björkman P, Medstrand P.
Pre-Treatment Integrase Inhibitor Resistance and Natural Polymorphisms among HIV-1 Subtype C Infected Patients in Ethiopia. Viruses. 2022; 14(4):729.
https://doi.org/10.3390/v14040729
Chicago/Turabian Style
Arimide, Dawit Assefa, Zsófia Ilona Szojka, Kidist Zealiyas, Atsbeha Gebreegziabxier, Fekadu Adugna, Sviataslau Sasinovich, Per Björkman, and Patrik Medstrand.
2022. "Pre-Treatment Integrase Inhibitor Resistance and Natural Polymorphisms among HIV-1 Subtype C Infected Patients in Ethiopia" Viruses 14, no. 4: 729.
https://doi.org/10.3390/v14040729
APA Style
Arimide, D. A., Szojka, Z. I., Zealiyas, K., Gebreegziabxier, A., Adugna, F., Sasinovich, S., Björkman, P., & Medstrand, P.
(2022). Pre-Treatment Integrase Inhibitor Resistance and Natural Polymorphisms among HIV-1 Subtype C Infected Patients in Ethiopia. Viruses, 14(4), 729.
https://doi.org/10.3390/v14040729